Filter
1224
Filtered Results: 1224
Text search:
in
vitro
Featured
Recommendations
145
New Publications
216
Language
Document type
No document type
477
Guidelines
356
Studies & Reports
194
Manuals
88
Fact sheets
51
Strategic & Response Plan
34
Training Material
12
Situation Updates
6
Resource Platforms
4
Brochures
1
Infographics
1
Countries / Regions
Latin America and the Carribbean
41
Brazil
41
Russia
36
India
31
Global
30
Colombia
25
Germany
25
South Africa
21
Paraguay
20
Argentina
17
Western and Central Europe
15
Mozambique
14
Africa
14
Venezuela
14
Sierra Leone
13
Bolivia
12
Angola
12
Peru
11
Ethiopia
10
Kenya
9
Middle East and North Africa
9
Ukraine
8
Rwanda
8
Cameroon
8
Burkina Faso
8
Eastern Europe
8
Zambia
8
Myanmar / Burma
8
Philippines
7
Tanzania
7
Spain
7
Uganda
7
Indonesia
7
Liberia
7
El Salvador
6
Syria
6
Nigeria
6
Eastern Europe and Central Asia
6
Namibia
6
Yemen
6
Chile
5
Guinea
5
West and Central Africa
5
South–East Asia Region
5
Ecuador
5
Senegal
4
Malawi
4
Italy
4
Haiti
4
Guinea-Bissau
4
France
4
Bangladesh
4
Nepal
3
Lesotho
3
Benin
3
Congo-Brazzaville
3
Niger
3
Congo, Democratic Republic of
3
East and Southern Africa
3
Mali
3
Eswatini/ Swaziland
3
Tajikistan
2
Ghana
2
Kazakhstan
2
Asia
2
Côte d’Ivoire / Ivory Coast
2
Vietnam
2
Sudan
2
Honduras
2
Chad
2
South Sudan
2
Madagascar
2
Guatemala
2
North Macedonia
1
Thailand
1
Mexico
1
Serbia
1
Turkey
1
Gambia
1
Togo
1
Albania
1
Canada
1
Laos
1
Kyrgyzstan
1
Uzbekistan
1
Afghanistan
1
Burundi
1
Zimbabwe
1
Morocco
1
Mongolia
1
Qatar
1
Mauritania
1
Armenia
1
USA
1
Dominican Republic
1
Jordan
1
Saudi Arabia
1
Luxembourg
1
North America
1
Belgium
1
Tunisia
1
Portugal
1
Belarus
1
Israel
1
Lebanon
1
Papua New Guinea
1
Nicaragua
1
Djibouti
1
Egypt
1
Palestine
1
Georgia
1
Libya
1
Iraq
1
Somalia
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
403
Clinical Guidelines
179
Pharmacy & Technologies
55
Public Health
36
Women & Child Health
36
Key Resources
27
Capacity Building
3
Toolboxes
COVID-19
271
TB
129
HIV
115
NTDs
83
AMR
58
Ebola & Marburg
47
Rapid Response
43
Pharmacy
37
Zika
31
Planetary Health
27
Mental Health
19
Caregiver
19
Refugee
18
Global Health Education
12
Health Financing Toolbox
6
NCDs
6
Conflict
6
Polio
6
Specific Hazards
5
Natural Hazards
4
Cholera
4
Disability
3
Malaria
3
Social Ethics
1
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
The objective of the 2022 Compendium is to compile and highlight emerging innovative health technologies for low-resource settings. It presents a snapshot of technologies that are solutions to an unmet medical/health technology need or are likely to improve health outcomes and the quality of life. H...
Prepared as an outcome of ICMR Expert Group on Immunophenotyping of Hematolymphoid Neoplasms | Coordinated by Division of Non Communicable Diseases | This document addresses on various issue related to good quality practices in laboratory work up of flow cytometric immunophenotyping and will be of u...
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby accelerate reduction in its prevalence. It comes at an important time, midway through the era of the Sustainable Development Goals, when progress in reduci...
These guidelines provide a framework for effective action to facilitate access to safe and ethical
testing services for different population groups. The implementation of the a comprehensive
approach, known as HIV Testing Services (HTS) is cardinal as an effective package of services
that diminis...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i...
The guidelines are to be used to guide the management of adults with lower respiratory tract infection (LRTI). As will be seen in the following text, this diagnosis, and the other clinical syndromes within this grouping, can be difficult to make accurately. In the absence of agreed definitions of th...
This is the 42nd situation report for the multi-country outbreak of mpox, which provides an update on the epidemiological situation of mpox in Africa (including countries in the WHO African Region and some countries in the WHO Eastern Mediterranean Region), with data as of 3 November 2024.
Full Perscribing information on Fexinidazole Tablet for oral use
INDICATIONS AND USAGE
Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in pati...
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells...
Modern healthcare has given rise to extremely complex and multifaceted ethical dilemmas. All too often physicians are unprepared to manage these competently. This publication is specifically structured to reinforce and strengthen the ethical mindset and prac...
TNew data from the World Health Organization reveal that the COVID-19 pandemic has disrupted malaria services, leading to a marked increase in cases and deaths.
According to WHO’s latest World malaria report, there were an estimated 241 million malaria cases and 627 000 malaria deaths worldwide i...
Über SARS-CoV-2-Testsysteme informieren das Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) und das Paul-Ehrlich-Institut. Die Informationen ergänzen sich, den rechtlichen Rahmen bietet u.a. die Coronavirus-Testverordnung-TestV.
Das BfArM bietet eine Liste von Antigen-Tests zum dir...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...
GDF is the largest global provider of quality-assured tuberculosis (TB)
medicines, diagnostics, and laboratory supplies to the public sector.
Since 2001, GDF has facilitated access to high-quality TB care in over 130
countries, providing treatments to over 30 million people with TB and procuring
...
HIV testing programmes need to ensure that all clients who test for HIV are provided with correct diagnoses. The accuracy of HIV testing is critical to prevent misdiagnosis, as the consequences of giving an incorrect test result can be serious for clients, HIV testing services, HIV programmes and pu...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
